Pure-play biotech VC spun out of Avalon Ventures in 2022. $135M Fund I. Managing Partners: Jay Lichter, Sandy Madigan, Tighe Reardon, Sergio Duron. Kevin Kinsella = Emeritus Partner. Incubation model with in-house labs. Notable exits: Nerio Therapeutics ($1.3B, Boehringer Ingelheim 2024), Calporta ($576M Merck).

LA seed-stage VC investing in technical teams reimagining major industries. 89 companies, 4 unicorns including Pluto TV, Procore, Tailscale. Founded by operators with roots in AdSense, Factual, Scopely.

$5.3B AUM. Growth equity and PE. Consumer, financial, health, travel verticals. Co-founder Raj Ganguly. Backed Lambda, Accacia, Carlsmed.

LA seed accelerator combining capital with collaborative community. Supports LA entrepreneurs as they build and scale. Founder: Paul Bricault.

La Jolla-based seed/early VC. $750M+ invested across 11 funds. Life sciences and tech. Founded by Kevin Kinsella. 125+ companies. Notable: Vertex, Synaptics, Vocera, Onyx Pharma. WSJ top biotech VC. [merged from 817]: San Diego's pioneering life sciences + tech VC. Founded 1983 by Kevin Kinsella. $750M+ deployed. Separate Avalon BioVentures fund ($135M, 2022) exclusively for early-stage biotech. Managing Partners: Jay Lichter, Sandy Madigan, Tighe Reardon. Accelerator model: incubates companies internally before bringing in co-investors. Notable: Erasca, Janux, Synthorx (acq. Sanofi $2.5B), Calporta (acq. Merck), Nerio (acq. Boehringer-Ingelheim $1.3B).

Consumer-focused VC combining venture capital with a startup studio. Backs companies transforming how people live, work, and play. Co-founders: Carter Reum and Courtney Reum.